According to records obtained by Business Insider, of the 28 complaints about uBiome submitted to the FTC between July 2017 and March 2019, 22 were from customers who received unexpected bills or whose insurance was billed for tests they did not receive. Other complaints detailed instances in which test results never arrived.
In one record, a patient claimed that after their spouse was mistakenly billed for the patient’s test, uBiome simply sent a bill to the patient without canceling the original $2,970 charge for their spouse’s nonexistent test. Another claimed that, though they were led to believe by uBiome that a test was covered by insurance, they ended up having to pay more than $2,000 out of pocket.
Since the FBI and others launched investigations into uBiome’s billing practices in late April, the company has placed its two co-founders on administrative leave and, earlier this week, suspended sales and processing of two of its microbiome tests.
More articles about health IT:
Study: App-based back pain treatment produces better results than physical therapy
Google is developing AI that can detect lung cancer earlier than trained radiologists
FDA clears AI-powered, cloud-based heart murmur detection system
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
